Looking at the competition the difference will mak
Post# of 148176
(Total Views: 447)
Posted On: 01/15/2020 2:02:47 PM
Looking at the competition the difference will make what efficacy we will see in patients , and what serious side effects are there .
Lets see few more patients , we may not have so much of competition for our with CCR5 expression patients..
IMO as always.
Lets see few more patients , we may not have so much of competition for our with CCR5 expression patients..
IMO as always.
(3)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼